Currently predicting for Thu, 4 Jun 2026

LLY Prediction Chart

LLY Predictions History

Latest community submissions for LLY.
Predictor Target Session Target Price Result Direction Accuracy Score
Oct 29, 2024 $902.16 +0.73% $903.58 V 99.84% 6
Oct 29, 2024 $899.69 +0.46% $903.58 V 99.57% 5
JS JS Pro
Oct 29, 2024 $897.62 +0.55% $903.58 V 99.34% 4
Oct 28, 2024 $899.53 +0.77% $895.59 V 99.56% 5
Oct 28, 2024 $896.97 +0.48% $895.59 V 99.85% 6
Oct 28, 2024 Bullish $895.59 V 1
Oct 28, 2024 Bullish $895.59 V 1
Oct 15, 2024 $924.82 -0.50% $913.32 V 98.74% 2
Oct 15, 2024 $922.01 -0.81% $913.32 V 99.05% 2
Oct 15, 2024 Bullish $913.32 X 0
Click to get the best stock tips daily for free!
Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for LLY with a full price path, not just a one-day call.
  • Price path
  • Approved predictor
  • 3-month horizon
ABOUT ELI LILLY AND COMPANY
Eli Lilly
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, Trajenta, and Trulicity for type 2 diabetes. The company provides Alimta for non-small cell lung cancer ...
GOLDEN STAR
Ticker Change Signal Date
LITE
$905.00
3.65% Jun 01
RUN
$12.83
15.74% May 06
GLBE
$31.61
0.569% May 05
SAP
$172.39
4.80% May 05
ADBE
$243.57
5.20% Apr 29

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE